• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Gyre Therapeutics` Hydronidone Meets Primary Endpoint in Phase 3

    GLOBENEWSWIRE

    Gyre Therapeutics Protocol for Phase 3 Trial on F351 in Journal

    GLOBENEWSWIRE

    Gyre Announces Publication in Journal of Gastroenterology and Hepatology

    GLOBENEWSWIRE

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.